Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

US Natural Gas Falls to a Six-Month Low, Down More Than 20% in Two Weeks, as Hedge Funds Hold a Record Short Bet

by Team Lumida
3 hours ago

US natural gas futures fell as much as 5.4% to the lowest since April on warmer forecasts, as hedge funds built the largest short position since at least...

Read more

A Democratic Sweep in the Midterms Is Seen as the Likeliest Trigger for a Bond Rally, With 58% Expecting Stocks to Fall

by Team Lumida
3 hours ago
wisconsin state capitol building usa

In Bloomberg’s Markets Pulse survey of 301 respondents, a Democratic sweep of Congress is seen as most likely to drive a Treasury rally and hurt the S&P 500.

Read more

Citadel Securities’ Shah Says the AI Trade Leaves “Precious Little Margin for Error” as Capex Becomes a Two-Sided Risk

by Team Lumida
3 hours ago
Hedge Fund Titans Citadel and Millennium Outperform Peers, Again!

Citadel Securities’ Nohshad Shah warns that with so much of the economy and market levered to AI, there is little room for error if spending fails.

Read more

Stock Futures Bounce After the S&P 500’s Losing Week as a Fed Decision and Microsoft, Alphabet and Amazon Earnings Loom

by Team Lumida
12 hours ago
Second-Largest Triple Witching on Record Sees $7 Trillion of Options Expire Friday, 60% of It at the Open

US stock futures rose Sunday after the S&P 500’s losing week, heading into a week with a Fed decision and earnings from Microsoft, Alphabet and Amazon.

Read more

BofA’s Hartnett Stays Risk-Off Until Mid-November and Says Markets Still Need to Price a Democratic Sweep

by Team Lumida
3 days ago

Bank of America’s Michael Hartnett expects a down-in-yields, down-in-stocks, down-in-dollar trade until mid-November as AI and midterm jitters linger.

Read more

Kalshi Plans the Only CPI Futures for a December Launch, Pitching Banks and Hedge Funds in a Challenge to CME

by Team Lumida
3 days ago
Kalshi logo over an abstract red swirl graphic

Kalshi is targeting a December launch for futures on headline and core CPI, and hired the “Inflation Guy” Michael Ashton to pitch big banks and hedge funds.

Read more

Dow Sheds More Than 500 Points as Brent Tops $116, VIX Breaks 20 and Telecoms Slide on SpaceX Wireless Push

by Team Lumida
3 days ago

The Dow fell more than 500 points Friday as Brent hit a six-month high, the VIX rose above 20 and telecom stocks slid on a SpaceX wireless report.

Read more

Gold Slipped Below $4,000 in a Liquidity-Driven Selloff as Fed Hike Odds for Next Week Fell Below 10%

by Team Lumida
3 days ago

Gold dipped below $4,000 an ounce to its lowest since mid-July as investors sold the metal to raise cash during the cross-market stock rout.

Read more

Global Corporate Bond Spreads Hit Their Widest Since May 2025 at Up to 129 Basis Points, and CreditSights Sees a Sustained Repricing

by Team Lumida
3 days ago

Global corporate bond spreads widened to their highest since May 2025 as the AI selloff pushed credit markets into their most risk-off stance in over a year.

Read more

The Nasdaq 100 Slid 2.4% Toward Its Worst Day Since June as Mideast Attacks Lifted Oil and Meta Fell 5.9%

by Team Lumida
4 days ago

Tech led US stocks lower as oil rose on Mideast attacks and Meta fell despite beating estimates, while Treasuries rallied as a haven.

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

D.C. Office Market Faces Uncertain Future—Election Results Won’t Save It

D.C. Office Market Faces Uncertain Future—Election Results Won’t Save It

July 23, 2024
Oracle’s Q4 earnings missed expectations but stock jumped ~11% after new cloud deals

Oracle’s AI Buildout Puts Its Bonds in the Crosshairs as Debt and Lease Commitments Surge

December 16, 2025
AI Investment Boom: How Tech Giants Are Leading the Charge

Pensions and Endowments Are Pushing Back on Private Equity’s AI Binge — Circular Deals and Hidden Concentration Alarm LPs

September 10, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018